Summary
This prediction ended on 06.02.23 with a price of €11.29. With a performance of 7.36%, the SELL prediction by BiotechBee for Snap Inc was trending in the wrong direction BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Snap Inc | -5.554% | -5.554% | -39.996% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to BiotechBee what are the pros and cons of Snap Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year